COMPARISON OF HEALTH CARE COSTS FOR CROHN'S DISEASE PATIENTS WHO ARE ADHERENT VERSUS INTERMITTENTLY ADHERENT WITH INFLIXIMAB THERAPY

被引：0
|
作者：
Feagan, B. [1 ]
Kozma, C. [2 ]
Slaton, T.
Olson, W. [3 ]
Wan, G. [4 ]
机构：
[1] Univ Western Ontario, Robarts Res Inst, London, ON, Canada
[2] Univ S Carolina, St Helena Isl, SC USA
[3] Janssen Sci Affairs LLC, Titusville, NJ USA
[4] Janssen Sci Affairs LLC, Horsham, PA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.048
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [1] HEALTH CARE COSTS FOR INFLAMMATORY BOWEL DISEASE PATIENTS WHO ARE ADHERENT VERSUS NON-ADHERENT WITH INFLIXIMAB THERAPY
    Wan, G.
    Kozma, C.
    Slaton, T.
    Olson, W.
    Feagan, B.
    VALUE IN HEALTH, 2012, 15 (04) : A102 - A102
  • [2] Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients
    Sunanda V. Kane
    Jingdong Chao
    Parvez M. Mulani
    Advances in Therapy, 2009, 26 : 936 - 946
  • [3] Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients
    Kane, Sunanda V.
    Chao, Jingdong
    Mulani, Parvez M.
    ADVANCES IN THERAPY, 2009, 26 (10) : 936 - 946
  • [4] COMPARING HEALTH CARE COSTS AND UTILIZATIONS OF PATIENTS WITH OVERACTIVE BLADDER WHO WERE ADHERENT AND NON-ADHERENT TO THEIR MEDICATION
    Xie, L.
    Khandelwal, N.
    Kariburyo, F.
    Baser, O.
    VALUE IN HEALTH, 2013, 16 (03) : A182 - A182
  • [5] HEALTH CARE COSTS BY LEVEL OF ADHERENCE FOR INFLIXIMAB PATIENTS WITH CROHN'S DISEASE
    Michels, S.
    Eyck, Ten L.
    Vanderpoel, J.
    Lofland, J.
    Ingham, M.
    Uribe, C.
    Denny, L.
    VALUE IN HEALTH, 2014, 17 (03) : A39 - A39
  • [6] Infliximab therapy for patients with Crohn's disease: Analysis of health care utilization
    Meek, Patrick D.
    Shah, Nilay D.
    Van Houten, Holly K.
    Gumustop, Bora
    Rosenberg, Marjorie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S452 - S452
  • [7] Health care resource use and costs for Crohn's disease before and after infliximab therapy
    Loomes, Dustin E.
    Teshima, Christopher
    Jacobs, Philip
    Fedorak, Richard
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (09): : 497 - 502
  • [8] A retrospective comparison of infliximab versus adalimumab as induction therapy for crohn's disease
    Varma, P.
    Huang, C.
    Paul, E.
    Headon, B.
    Sparrow, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 108 - 109
  • [9] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [10] COMPARISON OF DISEASE BURDEN BETWEEN SEVERE ASTHMA PATIENTS PERCEIVED BY THEIR PHYSICIAN AS HIGHLY ADHERENT TO THEIR BIOLOGIC THERAPY VERSUS THOSE NOT PERCEIVED AS HIGHLY ADHERENT
    Brown, S.
    Baskett, A.
    Cheng, B. Y.
    Yaacob, N. B.
    VALUE IN HEALTH, 2020, 23 : S349 - S349
12345